G
Generation Bio
Cambridge, United States
Founded 2018 NASDAQ: GBIO
About
Non-viral gene therapy using lipid nanoparticle delivery
Company Details
- Type
- public
- Employees
- 200+
- Funding
- Public
Key Products
- Non-Viral Gene Therapy
- ctLNP
Non-viral gene therapy using lipid nanoparticle delivery